Enhancer ID: | E_01_0690 |
Species: | human |
Position : | chr7:27159901-27161901 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Leukemia |
Pubmed ID: | 30270123 |
Enhancer experiment: | Flow Cytometry,Cell Proliferation and Colony Formation Assays,Immunoprecipitation,4C-seq Analysis,ChIP, ChIP-Seq and Bioinformatics Analyses,Real-time PCR and RNA-seq Analyses,Global Analysis on the Enhancer Landscape |
Enhancer experiment description: | Therapeutic targeting of HOXA9-dependent enhancer reorganization can be an effective therapeutic strategy in acute leukemia with HOXA9 overexpression. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Therapeutic targeting of HOXA9-dependent enhancer reorganization can be an effective therapeutic strategy in acute leukemia with HOXA9 overexpression. |
TF name : | HOXA9(D6a9,Hox-1.7) |
TF experiment: | Flow Cytometry,Cell Proliferation and Colony Formation Assays,Immunoprecipitation,4C-seq Analysis,ChIP, ChIP-Seq and Bioinformatics Analyses,Real-time PCR and RNA-seq Analyses,Global Analysis on the Enhancer Landscape |
TF experiment description: | Therapeutic targeting of HOXA9-dependent enhancer reorganization can be an effective therapeutic strategy in acute leukemia with HOXA9 overexpression. |
Enhancer function : | Therapeutic targeting of HOXA9-dependent enhancer reorganization can be an effective therapeutic strategy in acute leukemia with HOXA9 overexpression. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Therapeutic targeting of HOXA9-dependent enhancer reorganization can be an effective therapeutic strategy in acute leukemia with HOXA9 overexpression. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
HOXA9 | TGF_beta_Receptor | netpath | 220 |